












Andy Yeung
Founder at Asher Bio
Andy Yeung was the founder of Asher Bio which went through YC in S19. Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to enable selective activation of specific immune cell types, addressing the inherent limitations of otherwise pleiotropic immunotherapies that act on multiple cell types.
Follow Andy
Alumnus of

Massachusetts Institute of Technology

University of Wisconsin-Madison